Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes

por Bingley, Polly J., Wherrett, Diane K., Shultz, Ann, Rafkin, Lisa E., Atkinson, Mark A., Greenbaum, Carla J.
Publicado no Diabetes Care (2018)

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

por Sosenko, Jay M., Palmer, Jerry P., Rafkin, Lisa E., Krischer, Jeffrey P., Cuthbertson, David, Greenbaum, Carla J., Eisenbarth, George, Skyler, Jay S.
Publicado em 2010

Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study

por Bingley, Polly J., Rafkin, Lisa E., Matheson, Della, Steck, Andrea K., Yu, Liping, Henderson, Courtney, Beam, Craig A., Boulware, David C.
Publicado no Diabetes Technol Ther (2015)

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1)

por Sosenko, Jay M., Skyler, Jay S., Krischer, Jeffrey P., Greenbaum, Carla J., Mahon, Jeffrey, Rafkin, Lisa E., Cuthbertson, David, Cowie, Catherine, Herold, Kevan, Eisenbarth, George, Palmer, Jerry P.
Publicado em 2010

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients

por Sosenko, Jay M., Skyler, Jay S., Palmer, Jerry P., Krischer, Jeffrey P., Yu, Liping, Mahon, Jeffrey, Beam, Craig A., Boulware, David C., Rafkin, Lisa, Schatz, Desmond, Eisenbarth, George
Publicado em 2013

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

por Sosenko, Jay M., Skyler, Jay S., Beam, Craig A., Krischer, Jeffrey P., Greenbaum, Carla J., Mahon, Jeffrey, Rafkin, Lisa E., Matheson, Della, Herold, Kevan C., Palmer, Jerry P.
Publicado em 2013

A Comparison of the Baseline Metabolic Profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study Participants

por Sosenko, Jay M., Mahon, Jeffrey, Rafkin, Lisa, Lachin, John M., Krause-Steinrauf, Heidi, Krischer, Jeffrey P., Cuthbertson, David, Palmer, Jerry P., Thompson, Clinton, Greenbaum, Carla J., Skyler, Jay S.
Publicado em 2011

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral...

por Sosenko, Jay M., Skyler, Jay S., Herold, Kevan C., Schatz, Desmond A., Haller, Michael J., Pugliese, Alberto, Cleves, Mario, Geyer, Susan, Rafkin, Lisa E., Matheson, Della, Palmer, Jerry P.
Publicado no Diabetes (2020)

Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study

por Sosenko, Jay M., Skyler, Jay S., Mahon, Jeffrey, Krischer, Jeffrey P., Beam, Craig A., Boulware, David C., Greenbaum, Carla J., Rafkin, Lisa E., Cowie, Catherine, Cuthbertson, David, Palmer, Jerry P.
Publicado em 2011

The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes

por Sosenko, Jay M., Skyler, Jay S., Mahon, Jeffrey, Krischer, Jeffrey P., Beam, Craig A., Boulware, David C., Greenbaum, Carla J., Rafkin, Lisa E., Cowie, Catherine, Cuthbertson, David, Palmer, Jerry P.
Publicado em 2012

Erratum. Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785–1787

por Sosenko, Jay M., Skyler, Jay S., Mahon, Jeffrey, Krischer, Jeffrey P., Beam, Craig A., Boulware, David C., Greenbaum, Carla J., Rafkin, Lisa E., Cowie, Catherine, Cuthbertson, David, Palmer, Jerry P.
Publicado no Diabetes Care (2018)

The Influence of Body Mass Index and Age on C-peptide at the Diagnosis of Type 1 Diabetes in Children Who Participated in the Diabetes Prevention Trial-Type 1

por Sosenko, Jay M., Geyer, Susan, Skyler, Jay S., Rafkin, Lisa E., Ismail, Heba M., Libman, Ingrid M., Liu, Yuk-Fun, DiMeglio, Linda A., Evans-Molina, Carmella, Palmer, Jerry P.
Publicado no Pediatr Diabetes (2017)

The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months

por Sosenko, Jay M., Skyler, Jay S., Beam, Craig A., Boulware, David, Mahon, Jeffrey L., Krischer, Jeffrey P., Greenbaum, Carla J., Rafkin, Lisa E., Matheson, Della, Herold, Kevan C., Palmer, Jerry P.
Publicado no Diabetes Care (2015)

A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History

por Sosenko, Jay M., Skyler, Jay S., DiMeglio, Linda A., Beam, Craig A., Krischer, Jeffrey P., Greenbaum, Carla J., Boulware, David, Rafkin, Lisa E., Matheson, Della, Herold, Kevan C., Mahon, Jeffrey, Palmer, Jerry P.
Publicado no Diabetes Care (2015)

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes

por Sosenko, Jay M., Skyler, Jay S., Mahon, Jeffrey, Krischer, Jeffrey P., Greenbaum, Carla J., Rafkin, Lisa E., Beam, Craig A., Boulware, David C., Matheson, Della, Cuthbertson, David, Herold, Kevan C., Eisenbarth, George, Palmer, Jerry P.
Publicado em 2014

Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes

por Ismail, Heba M., Evans-Molina, Carmella, DiMeglio, Linda A., Becker, Dorothy J., Libman, Ingrid, Sims, Emily K., Boulware, David, Herold, Kevan C., Rafkin, Lisa, Skyler, Jay, Cleves, Mario A., Palmer, Jerry, Sosenko, Jay M.
Publicado no Pediatr Diabetes (2019)

Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention

por Sims, Emily K., Geyer, Susan, Johnson, Suzanne Bennett, Libman, Ingrid, Jacobsen, Laura M., Boulware, David, Rafkin, Lisa E., Matheson, Della, Atkinson, Mark A., Rodriguez, Henry, Spall, Maria, Elding Larsson, Helena, Wherrett, Diane K., Greenbaum, Carla J., Krischer, Jeffrey, DiMeglio, Linda A.
Publicado no Diabetes Care (2019)

Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention. Diabetes Care 2019;42:2228–2236

por Sims, Emily K., Geyer, Susan, Johnson, Suzanne Bennett, Libman, Ingrid, Jacobsen, Laura M., Boulware, David, Rafkin, Lisa E., Matheson, Della, Atkinson, Mark A., Rodriguez, Henry, Spall, Maria, Larsson, Helena Elding, Wherrett, Diane K., Greenbaum, Carla J., Krischer, Jeffrey, DiMeglio, Linda A.
Publicado no Diabetes Care (2020)

Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial

por Lanzoni, Giacomo, Linetsky, Elina, Correa, Diego, Messinger Cayetano, Shari, Alvarez, Roger A., Kouroupis, Dimitrios, Alvarez Gil, Ana, Poggioli, Raffaella, Ruiz, Phillip, Marttos, Antonio C., Hirani, Khemraj, Bell, Crystal A., Kusack, Halina, Rafkin, Lisa, Baidal, David, Pastewski, Andrew, Gawri, Kunal, Leñero, Clarissa, Mantero, Alejandro M. A., Metalonis, Sarah W., Wang, Xiaojing, Roque, Luis, Masters, Burlett, Kenyon, Norma S., Ginzburg, Enrique, Xu, Xiumin, Tan, Jianming, Caplan, Arnold I., Glassberg, Marilyn K., Alejandro, Rodolfo, Ricordi, Camillo
Publicado no Stem Cells Transl Med (2021)